| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |